cases, 335930 recoveries and 4530 deaths. as of 15 january, the total number of cases was 364555, including 21541 active cases, 338453 cures and 4561 deaths. as of 25 january, the total number of cases in the ut was 409166, including 47376 active cases, 357163 recoveries and 4627 deaths. as of 11 february, the total number of cases was 449873, including 7424 active cases, 437708 recoveries and 4741 fatal cases. as of 21 february, the total number of cases was 452410, including 1692 active cases, 445971 cures and 4747 deaths. as of 19 march, the total number of cases was 453520, including 133 active cases, 448637 cures and 4750 deaths. april to june 2022 as of 14 april, the total number of cases in jammu and kashmir was 453909, including 77 active cases, 449082 cures and 4750 deaths. as of 30 april, the total number of cases was 454047, including 66 active cases, 449230 recoveries and 4751 deaths. as of 10 may, the total number of cases was 454113, including 56 active cases, 449306 recoveries and 4751 deaths. as of 13 may, the total number of cases was 454125, including 57 active cases, 449317 cures and 4751 deaths. as of 28 may, the total number of cases was 454227, including 63 active cases, 449412 recoveries and 4752 deaths. as of 31 may, the total number of cases was 454248, including 64 active cases, 449432 recoveries and 4752 fatal cases. as of 10 june, the total number of cases was 454314, including 68 active cases, 449494 cures and 4752 fatal cases. as of 16 june, the total number of cases was 454420, including 126 active cases, 449542 cures and 4752 deaths. july to september 2022 as of 9 july, the total number of cases in jammu and kashmir was 455807, including 692 active cases, 450358 cures and 4757 deaths. as of 26 august, the total number of cases was 477119, including 1835 active cases, 470502 recoveries and 4782 deaths. as of 31 august, the total number of cases was 477784, including 1091 active cases, 471911 cures and 4782 fatal cases. as of 10 september, the total number of cases was 478685, including 480 active cases, 473421 cures and 4784 deaths. as of 24 september, the total number of cases was 479062, including 168 active cases, 474109 recoveries and 4785 deaths. covid-19 vaccines with approval for emergency or conditional usage union minister for health & family welfare, dr. harsh vardhan visiting the gtb hospital, shahdara to review the preparedness of dry run of covid-19 vaccine, in delhi on january 02, 2021. main article: covid-19 vaccine covishield on january 1, 2021, the drug controller general of india, approved the emergency or conditional use of astrazeneca’s covid-19 vaccine azd1222 (marketed as covishield). covishield is developed by the university of oxford and its spin-out company, vaccitech. it's a viral vector vaccine based on replication-deficient adenovirus that causes cold in chimpanzees. it can be stored, transported and handled at normal refrigerated conditions (two-eight degrees celsius/ 36-46 degrees fahrenheit). it has a shelf-life of at least six months. on 12 january 2021 first batches of covishield vaccine was despatched from the serum institute of india. covaxin on january 2, 2021, bbv152 (marketed as covaxin), first indigenous vaccine, developed by bharat biotech in association with the indian council of medical research and national institute of virology received approval from the drug controller general of india for its emergency or conditional usage. on 14 january 2021 first batches of covaxin vaccine was despatched from the bharat biotech, albeit it was still in the third phase of testing. others on 19 may 2021, dr reddy's labs received emergency use authorisation for anti-covid drug 2-dg. on 21 february, 2022, drugs controller general of india granted approval to biological e's covid-19 vaccine corbevax, that can be used for children between 12-18 years of age. on 21 october 2021, india completed administering of one billion covid vaccines in the country. on 8 january 2022, india crossed 1.5 billion covid vaccines milestone in the country. on 19 february 2022, india crossed 1.75 billion covid vaccines milestone in the country.